Podcast: Celltrion’s Subcutaneous Infliximab And The Future Of Biosimilars

We Discuss The Celltrion Product Breaking New Ground For Biosimilars

 
• By Dave Wallace
Microphone
David Wallace And Duncan Emerton Discuss Celltrion’s Subcutaneous Remsima • Source: Shutterstock

More from Biosimilars

More from Products